↓ Skip to main content

Immune-checkpoint inhibitors for glioblastoma: what have we learned?

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, May 2022
Altmetric Badge

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
Published in
Arquivos de Neuro-Psiquiatria, May 2022
DOI 10.1590/0004-282x-anp-2022-s129
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 5 13%
Student > Master 2 5%
Researcher 2 5%
Student > Postgraduate 2 5%
Unspecified 1 3%
Other 1 3%
Unknown 26 67%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 5 13%
Biochemistry, Genetics and Molecular Biology 3 8%
Veterinary Science and Veterinary Medicine 1 3%
Arts and Humanities 1 3%
Unspecified 1 3%
Other 2 5%
Unknown 26 67%